.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Teva
Moodys
Express Scripts
Mallinckrodt
Harvard Business School
Boehringer Ingelheim
QuintilesIMS
Baxter
US Department of Justice

Generated: December 14, 2017

DrugPatentWatch Database Preview

Patents Expiring in February 2020

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Pharmacia And UpjohnDETROL LAtolterodine tartrateCAPSULE, EXTENDED RELEASE;ORAL021228-001Dec 22, 2000ABRXYesNo► Subscribe► Subscribe► SubscribeY
Pharmacia And UpjohnDETROL LAtolterodine tartrateCAPSULE, EXTENDED RELEASE;ORAL021228-002Dec 22, 2000ABRXYesYes► Subscribe► Subscribe► SubscribeY
Boehringer IngelheimSTRIVERDI RESPIMATolodaterol hydrochlorideSPRAY, METERED;INHALATION203108-001Jul 31, 2014RXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), CHRONIC BRONCHITIS OR EMPHYSEMA
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYesYes► Subscribe► Subscribe► SubscribeY
Helsinn HlthcareAKYNZEOnetupitant; palonosetron hydrochlorideCAPSULE;ORAL205718-001Oct 10, 2014RXYesYes► Subscribe► Subscribe► SubscribeY
AegerionJUXTAPIDlomitapide mesylateCAPSULE;ORAL203858-006Apr 23, 2015RXYesYes► Subscribe► Subscribe► SubscribeYYTREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA AND HYPERLIPOPROTEINEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
AegerionJUXTAPIDlomitapide mesylateCAPSULE;ORAL203858-001Dec 21, 2012RXYesNo► Subscribe► Subscribe► SubscribeYYTREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA AND HYPERLIPOPROTEINEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
AegerionJUXTAPIDlomitapide mesylateCAPSULE;ORAL203858-002Dec 21, 2012RXYesNo► Subscribe► Subscribe► SubscribeYYTREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA AND HYPERLIPOPROTEINEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
AegerionJUXTAPIDlomitapide mesylateCAPSULE;ORAL203858-003Dec 21, 2012RXYesNo► Subscribe► Subscribe► SubscribeYYTREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA AND HYPERLIPOPROTEINEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
AegerionJUXTAPIDlomitapide mesylateCAPSULE;ORAL203858-004Apr 23, 2015RXYesNo► Subscribe► Subscribe► SubscribeYYTREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA AND HYPERLIPOPROTEINEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Cerilliant
Fuji
Novartis
Cantor Fitzgerald
Queensland Health
Federal Trade Commission
US Department of Justice
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot